KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bionano Genomics (BNGO) Other Non-Current Liabilities (2017 - 2024)

Bionano Genomics (BNGO) has disclosed Other Non-Current Liabilities for 8 consecutive years, with $5.8 million as the latest value for Q2 2024.

  • Quarterly Other Non-Current Liabilities fell 60.37% to $5.8 million in Q2 2024 from the year-ago period, while the trailing twelve-month figure was $5.8 million through Jun 2024, down 60.37% year-over-year, with the annual reading at $10.9 million for FY2023, 16.04% down from the prior year.
  • Other Non-Current Liabilities hit $5.8 million in Q2 2024 for Bionano Genomics, down from $10.2 million in the prior quarter.
  • In the past five years, Other Non-Current Liabilities ranged from a high of $14.9 million in Q3 2023 to a low of $75000.0 in Q3 2020.
  • Historically, Other Non-Current Liabilities has averaged $9.2 million across 5 years, with a median of $10.6 million in 2023.
  • Biggest five-year swings in Other Non-Current Liabilities: skyrocketed 209.33% in 2021 and later plummeted 60.37% in 2024.
  • Year by year, Other Non-Current Liabilities stood at $75000.0 in 2020, then surged by 11988.0% to $9.1 million in 2021, then skyrocketed by 43.06% to $13.0 million in 2022, then dropped by 16.04% to $10.9 million in 2023, then tumbled by 46.98% to $5.8 million in 2024.
  • Business Quant data shows Other Non-Current Liabilities for BNGO at $5.8 million in Q2 2024, $10.2 million in Q1 2024, and $10.9 million in Q4 2023.